Residual Symptoms After Coronavirus Disease (COVID-19) in Lithuanian Population
Post-Covid
Residual Symptoms in Patients With a History of Coronavirus Disease (COVID-19) and Their Impact on Biopsychosocial Functions (Post-Covid Syndrome)
1 other identifier
observational
5,000
1 country
1
Brief Summary
The aim of the study is to describe the post-covid-19 syndrome in Lithuanian population regarding the remaining symptoms and their impact on physical functioning, work ability and needs of rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 4, 2021
CompletedFirst Submitted
Initial submission to the registry
July 16, 2021
CompletedFirst Posted
Study publicly available on registry
August 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedAugust 11, 2021
August 1, 2021
1.7 years
July 16, 2021
August 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Description of post-covid-19 syndrome in Lithuanian population
Post-covid-19 syndrome in Lithuanian population: prevalence, symptomatology and needs of rehabilitation
2021.05.04 - 2022.12.31
Secondary Outcomes (1)
Assessment of medical premorbid status in post-covid-19 syndrome
2021.05.04 - 2022.12.31
Eligibility Criteria
The online study will be open to all volunteers over the age of 18 with COVID-19 infection
You may qualify if:
- older than 18 years age patients;
- a history of COVID-19 infection that was and was not positive for SARS-CoV-2 diagnostic or antibody testing
- the duration of remaining symptoms is longer than 28 days
- ability to fulfil internet-based questionnaire
You may not qualify if:
- ongoing covid-19 infection
- other comorbidities requiring treatment or rehabilitation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lithuanian University of Health Scienceslead
- Karolinska Institutetcollaborator
Study Sites (1)
Lithuanian University of Health Sciences
Kaunas, 44307, Lithuania
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD-student
Study Record Dates
First Submitted
July 16, 2021
First Posted
August 11, 2021
Study Start
May 4, 2021
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
August 11, 2021
Record last verified: 2021-08